.Nature Medicine, Published online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Perspective asks for inclusion of people with MASLD and measurement of liver outcomes in cardio-- kidney-- metabolic tests, when records advise mechanistically possible perks as well as clinical protection-- and describes factors for test concept as well as regulative approval.